FIELD: medicine.
SUBSTANCE: invention relates to an application of benzyl 6-({2-[(3,4-dimethylphenyl)amino]-2-oxoethyl}thio)-2-methyl-4-(4-chlorophenyl)-5-cyano-1,4-dihydropyridine-3-carboxylate by the formula (I) as a hepatoprotective agent.
(I).
EFFECT: proposed is a newly found field of application of a compound by the formula (I) in medicine as a hepatoprotective agent.
1 cl, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
USE OF 2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4 -DIHYDROPYRIDINE-3-CARBOXAMIDE AS HYPOGLYCEMIC, HYPOLIPIDEMIC AGENT THAT PROMOTES WEIGHT LOSS | 2023 |
|
RU2812569C1 |
2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4-DIHYDROPYRIDINE-3-CARBOXAMIDE EXHIBITING ANALGESIC PROPERTIES | 2023 |
|
RU2813896C1 |
4-(2-METHYL-6-{[2-(DIPHENYLAMINO)-2-OXOETHYL]THIO}-4-FUR-2-YL-5-CYANO-1,4-DIHYDROPYRIDINE-3-CARBOXAMIDO)BENZOIC ACID ETHYL ETHER SHOWING ANTI-INFLAMMATORY PROPERTIES | 2022 |
|
RU2792595C1 |
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
APPLICATION OF MAGNESIUM COMPOUND WITH HEPATOPROTECTIVE ACTIVITY, FOR ALCOHOL AND MEDICINAL HEPATITIS TREATMENT | 2016 |
|
RU2629606C1 |
AGENT POSSESSING HEPATOPROTECTIVE ACTION | 2020 |
|
RU2727931C1 |
HEPATOPROTECTIVE ACTION OF GARCINOL | 2011 |
|
RU2585245C2 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
COMPOSITIONS, METHODS AND MEDICAL COMPOSITIONS FOR TREATMENT AND MAINTENANCE OF LIVER HEALTH | 2016 |
|
RU2755478C2 |
COMPOSITIONS, METHODS AND MEDICAL COMPOSITIONS FOR TREATMENT AND MAINTENANCE OF LIVER HEALTH | 2016 |
|
RU2755475C2 |
Authors
Dates
2021-09-15—Published
2021-02-16—Filed